Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Pharma
Novartis gears up for Pluvicto filing as survival data clear up
Although Pluvicto has flipped a previously negative overall survival trend, question remains as to whether the positive direction is sustainable.
Angus Liu
Apr 5, 2024 3:00am
How those in the public eye are boosting disease awareness
Feb 28, 2024 10:10am
Eli Lilly hit with Verzenio flop in prostate cancer
Feb 7, 2024 10:44am
Pfizer pumps $15M into ACS' cancer screening health equity push
Feb 6, 2024 5:26am
Exelixis joins Novartis on FDA waiting list in prostate cancer
Jan 25, 2024 8:00am
Florida's drug importation authorization draws industry backlash
Jan 6, 2024 4:38pm